✦ LIBER ✦

CN2 COST-EFFECTIVENESS ANALYSIS OF RITUXIMAB + CHOP VERSUS CHOP IN PATIENTS WITH AGGRESSIVE NONHODGKIN LYMPHOMA

✍ Scribed by P Berto; A Morsanutto; S Lopatriello

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN28 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ D Cortina; R Rivera-Hurtado; C Aleman; I Egoavil; L Gonzalez-Michaca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cost-Effectiveness Analysis of Rituximab

✍ Jennie H. Best; John Hornberger; Stephen J. Proctor; Louis F. Omnes; Fred Jost 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

PCN12 COST-EFFECTIVENESS ANALYSIS OF G-C

✍ GH Lyman; LE Cosier 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Cost-Effectiveness Analysis of the Addit

✍ Felicetto Ferrara, Dr Roberto Ravasio 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Comparison of CHOP versus CIOP in good p

✍ C. Burton; P. Smith; G. Vaughan-Hudson; W. Qian; P. Hoskin; D. Cunningham; B. Ha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Long-term update of a phase II study of

✍ Vose, J. M.; Link, B. K.; Grossbard, M. L.; Czuczman, M.; Grillo-Lopez, A.; Fish 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 205 KB